Physician profile
Ginger Wille
NPI 1396508990
$1,083.42
in general payments reported to CMS, 2019-2025
16 companies · $640 in 2025
The $640 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $443 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $281.54 | 2024-2025 | Evenity, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $135.72 | 2024 | |
| Merck Sharp & Dohme LLC | $111.05 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Pfizer INC. | $83.39 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $68.02 | 2025 | Voquezna |
| Lilly USA, LLC | $67.54 | 2024-2025 | Zepbound, Mounjaro, Kisunla |
| Abbvie INC. | $61.26 | 2025 | |
| Exact Sciences Corporation | $46.25 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $39.49 | 2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.14 | 2024-2025 | Jardiance, Tradjenta |
| Glaxosmithkline, LLC. | $36.97 | 2024-2025 | Shingrix, Arexvy, Penmenvy |
| Aimmune Therapeutics, INC. | $33.85 | 2025 | Vowst |
| Sumitomo Pharma America, INC. | $23.23 | 2025 | Gemtesa |
| Alexion Pharmaceuticals, INC. | $21.00 | 2025 | Strensiq |
| Astrazeneca Pharmaceuticals Lp | $19.83 | 2024 | Airsupra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.14 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Wille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.